Cancer Research Meeting Calendar  EMT and Cancer Progression and Treatment
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4715-4719, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Badcock, G.
Right arrow Articles by Andrews, P. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Badcock, G.
Right arrow Articles by Andrews, P. W.
[Cancer Research 59, 4715-4719, September 15, 1999]
© 1999 American Association for Cancer Research


Tumor Biology

The Human Embryonal Carcinoma Marker Antigen TRA-1-60 Is a Sialylated Keratan Sulfate Proteoglycan

Graeme Badcock, Christine Pigott, John Goepel and Peter W. Andrews1

Departments of Biomedical Science [G. B., C. P., P. W. A.] and Pathology [J. G.], University of Sheffield, Western Bank, Sheffield S10 2TN, United Kingdom

Human embryonal carcinoma (EC) cells are the stem cells of teratocarcinomas, and they are key components of germ cell tumors (GCTs). They express several high molecular weight glycoprotein antigens that are down-regulated upon differentiation. One of these antigens, defined by monoclonal antibody TRA-1-60, can be detected in the serum of GCT patients and provides a useful complement to the established serum markers human chorionic gonadotropin and {alpha}-fetoprotein, especially in those patients without elevated serum human chorionic gonadotropin or {alpha}-fetoprotein. To examine the relationship of the TRA-1-60-defined antigen to similar antigens defined by other monoclonal antibodies, we have carried out comparative Western blot and immunoprecipitation analyses of human GCT-derived cell lines with monoclonal antibodies TRA-1-60, TRA-1-81, GCTM2, and K21. The TRA-1-60 antigen was detected by Western blot analysis in extracts of all human EC cell lines and in clinical specimens of GCT tested as a diffuse band with a molecular weight of >200,000. A similar but noticeably fainter band was detected in GCT composed of seminoma only. The antigen was not expressed by GCT-derived lines without an EC phenotype. Affinity bead-purified TRA-1-60, TRA-1-81, GCTM2 and K21 antigens reacted in Western blot analysis with each of the other antibodies tested, indicating that the epitopes recognized by each antibody are carried by the same molecular species. This molecule could be metabolically labeled with inorganic [35S]sulfate and was degraded by keratanase. Glycopeptides produced from affinity-purified TRA-1-60 antigen by extensive digestion with Pronase exhibited a molecular weight in excess of 10,000 and were degraded by keratanase. The TRA-1-60 epitope was destroyed by digestion with neuraminidase, but the epitopes defined by TRA-1-81, GCTM2, and K21 were not. Our results indicate that human EC cells generally express a cell surface sialylated keratan sulfate proteoglycan that is subject to modification to yield a variety of epitopes, one of which is recognized by the monoclonal antibody TRA-1-60. Sensitivity to milk alkaline digestion suggests that the oligosaccharides of this proteoglycan are O-linked to a core polypeptide.




This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
E. Rajpert-De Meyts
Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects
Hum. Reprod. Update, May 1, 2006; 12(3): 303 - 323.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Yamagishi, K. Suzuki, K. Imai, H. Mochizuki, K. Morikawa, M. Kyogashima, K. Kimata, and H. Watanabe
Purification, Characterization, and Molecular Cloning of a Novel Keratan Sulfate Hydrolase, Endo-{beta}-N-acetylglucosaminidase, from Bacillus circulans
J. Biol. Chem., July 3, 2003; 278(28): 25766 - 25772.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
C. M. Verfaillie, M. F. Pera, and P. M. Lansdorp
Stem Cells: Hype and Reality
Hematology, January 1, 2002; 2002(1): 369 - 391.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
B.E. Reubinoff, M.F. Pera, G. Vajta, and A.O. Trounson
Effective cryopreservation of human embryonic stem cells by the open pulled straw vitrification method
Hum. Reprod., October 1, 2001; 16(10): 2187 - 2194.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
M. Pera, B Reubinoff, and A Trounson
Human embryonic stem cells
J. Cell Sci., January 1, 2000; 113(1): 5 - 10.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.